Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 6—June 2010


Xenotropic Murine Leukemia Virus–related Gammaretrovirus in Respiratory Tract

Nicole FischerComments to Author , Claudia Schulz, Kristin Stieler, Oliver Hohn, Christoph Lange, Christian Drosten, and Martin Aepfelbacher
Author affiliations: University Medical Center Hamburg-Eppendorf, Hamburg, Germany (N. Fischer, C. Schulz, K. Stieler, M. Aepfelbacher); Robert Koch-Institute, Berlin, Germany (O. Hohn); Leibniz-Center for Medicine and Biosciences, Borstel, Germany (C. Lange); University of Bonn Medical Centre, Bonn, Germany (C. Drosten)

Main Article


Detection of XMRV in respiratory tract secretions from 329 persons*

Group Patient median age, y Underlying disease Sample XMRV+
1 (75 patients with RTI) 42 None Sputum, nasal swab 3/75 (2.3%)
2 (31 patients with RTI) 60 COPD BAL 1/31 (3.2%)
3 (161 patients with RTI) 32 Immunosuppression after SOT or BMT BAL, TS 16/161 (9.9%)
Control (62 persons with no RTI) 35 None BAL, throat swab 2/62 (3.2%)

*XMRV, xenotropic murine leukemia virus; +, positive for XMRV–specific sequences by PCR; RTI, respiratory tract infection; COPD, chronic obstructive pulmonary disease; BAL, bronchoalveolar lavage; SOT, solid organ transplantation; BMT, bone marrow transplantation; TS, tracheal secretion.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO